Kroger Health and Gravity Diagnostics Partner to Offer 3-in-1 Multiplex Testing at all Kroger Little Clinics
20 janv. 2022 13h17 HE
|
Gravity Diagnostics
Covington, Kentucky, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Gravity Diagnostics’ 3-in-1 multiplex tests for flu A/B, RSV, and COVID-19 combined, to help differentiate these three types of infections in...
7 Hills Pharma Announces the Completion of a Landmark Phase I Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
01 nov. 2021 15h08 HE
|
7 Hills Pharma
HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), a clinical-stage drug development company bringing to market a platform of unique, first-in-concept oral small...
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
17 févr. 2021 07h04 HE
|
Vir Biotechnology, Inc.
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza – – Functional genomics...
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
09 déc. 2020 08h02 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Stop & Shop Now Offering Flu Shots to Children Three Years and Older in Massachusetts
03 déc. 2020 11h16 HE
|
Stop and Shop
QUINCY, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Stop & Shop, a neighborhood grocer for more than 100 years, announced today that flu shots are now available to Massachusetts children three...
Ricky Sitomer, CEO of Star Jets International, Inc. (JETR), Announces Record $3,000,000+ in Revenue for the Third Quarter of 2020
24 nov. 2020 11h22 HE
|
Star Jets International
NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Star Jets International, Inc. (OTCPink: JETR), a leading Private Jet Charter Company, announces that the Company booked in excess of $3,000,000 million...
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
16 nov. 2020 11h20 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
AAFA Receives CDC Funding Award to Improve Asthma Care and Outcomes for At-Risk Populations Through Comprehensive Community Health Interventions
29 oct. 2020 14h49 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is spearheading yet another new venture geared toward improving health outcomes for our...
Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020
21 oct. 2020 08h00 HE
|
Vir Biotechnology, Inc.
– Preclinical data show VIR-2482 has broad neutralizing potential against all major strains of influenza A from the last 100 years – – Extended half-life observed in Phase 1 demonstrates potential...
Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure
13 oct. 2020 08h00 HE
|
Novavax, Inc.
Team will focus on global NanoFlu licensure and evaluation of post-pandemic influenza/COVID-19 combination vaccine with NVX-CoV2373 Russell (Rip) Wilson promoted to Executive Vice President and...